HCA Healthcare (NYSE:HCA) Price Target Raised to $375.00 at Deutsche Bank Aktiengesellschaft

HCA Healthcare (NYSE:HCA) had its price objective boosted by Deutsche Bank Aktiengesellschaft from $359.00 to $375.00 in a research note released on Friday, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

A number of other brokerages have also recently issued reports on HCA. Oppenheimer upped their target price on HCA Healthcare from $330.00 to $345.00 and gave the stock an outperform rating in a report on Monday, April 29th. Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $303.00 to $315.00 and gave the stock an equal weight rating in a research report on Thursday, March 28th. Barclays lifted their price target on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an overweight rating in a report on Monday, April 29th. StockNews.com lowered HCA Healthcare from a strong-buy rating to a buy rating in a research report on Sunday, June 16th. Finally, TD Cowen lowered their price objective on HCA Healthcare from $371.00 to $360.00 and set a buy rating for the company in a research report on Tuesday, April 30th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of Moderate Buy and an average price target of $326.53.

HCA Healthcare Trading Down 6.4 %

Shares of HCA opened at $321.28 on Friday. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16. HCA Healthcare has a 52-week low of $215.96 and a 52-week high of $344.20. The firm has a market cap of $84.15 billion, a price-to-earnings ratio of 16.02, a PEG ratio of 1.58 and a beta of 1.69. The business’s fifty day moving average is $325.96 and its 200-day moving average is $317.53.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The company had revenue of $17.34 billion for the quarter, compared to the consensus estimate of $16.81 billion. During the same period last year, the company posted $4.93 EPS. The firm’s quarterly revenue was up 11.2% compared to the same quarter last year. Equities analysts anticipate that HCA Healthcare will post 20.92 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Friday, June 14th were given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.82%. The ex-dividend date of this dividend was Friday, June 14th. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the sale, the senior vice president now owns 22,365 shares in the company, valued at approximately $6,977,880. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael S. Cuffe sold 6,311 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the transaction, the executive vice president now owns 29,624 shares in the company, valued at $9,387,253.12. The disclosure for this sale can be found here. Over the last three months, insiders have sold 12,397 shares of company stock valued at $3,921,929. Corporate insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

A number of hedge funds have recently made changes to their positions in HCA. Stone House Investment Management LLC purchased a new position in HCA Healthcare in the third quarter valued at about $25,000. Centerpoint Advisors LLC purchased a new stake in HCA Healthcare in the fourth quarter worth $27,000. Atlantic Edge Private Wealth Management LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth $27,000. LifeSteps Financial Inc. bought a new stake in HCA Healthcare in the 1st quarter valued at about $33,000. Finally, Bruce G. Allen Investments LLC bought a new position in HCA Healthcare during the fourth quarter worth about $28,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.